This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

KMG Chemicals Reports Fiscal 2011 Fourth Quarter And Full Year Financial Results

Stocks in this article: KMGB

KMG Chemicals, Inc. (NASDAQ GS: KMGB), a global provider of specialty chemicals in carefully focused markets, today announced financial results for its fiscal fourth quarter and year ended July 31, 2011.

Consolidated Overview

Net sales in the fiscal 2011 fourth quarter increased 19% to $74.2 million from $62.5 million in the fourth quarter of 2010. Operating income in the fiscal 2011 fourth quarter was $2.7 million compared to $6.3 million in the fourth quarter of last year. KMG recorded net income of $1.2 million, or $0.10 per diluted share, for the fourth quarter of fiscal 2011, compared to net income of $3.4 million, or $0.30 per diluted share, in the fourth quarter of last year.

For the 2011 fiscal year, net sales were $266.4 million, operating income was $17.7 million, and net income was $9.7 million or $0.85 per diluted share. This compared to net sales of $208.6 million, operating income of $27.0 million, and net income of $15.3 million, or $1.34 per diluted share, in fiscal 2010.

Higher sales for the fiscal 2011 fourth quarter and full year were due primarily to increased sales of Electronic Chemicals and higher volumes of Creosote in the Wood Treating Chemicals business. The operating income declines in the fiscal 2011 fourth quarter and full year were primarily driven by higher raw material costs and distribution costs, along with integration expenses associated with the consolidation of manufacturing following the latest Electronic Chemicals acquisition. As previously announced, the Electronic Chemicals plant consolidation has been completed and the resulting operating efficiencies are expected to be realized in fiscal 2012. Moreover, the pricing actions taken by KMG in the second half of fiscal 2011 to offset raw material cost increases are expected to benefit margins in fiscal 2012.

Business Unit Overview and Trends

Net Sales & Operating Income by Business ($ in millions; includes effects of rounding)

           
    Three Months Ended

July 31

    Year Ended

July 31

    Net Sales / % of Total    

Operating Income

  Net Sales / % of Total    

Operating Income

    2011     2010     2011     2010     2011     2010     2011     2010

Electronic Chemicals

  $ 40.2 / 54 %     $ 36.5 / 59 %     $ .262     $ 2.8     $ 151.5 / 57 %     $ 112.0 / 54 %     $ 6.2     $ 8.4  

Wood Treating Chemicals

  $ 30.7 / 42 %     $ 22.0 / 35 %     $ 3.4     $ 4.7   $ 104.1 / 39 %     $ 86.0 / 41 %     $ 14.8     $ 23.0  
Animal Health   $ 3.3 / 4 %     $ 4.0 / 6 %     $ .002     $ (.031 ) $ 10.8 / 4 %     $ 10.6 / 5 %     $ .061     $ (.086 )
Total   $ 74.2       $ 62.5                 $ 266.4       $ 208.6              

Allocation of Corporate Overhead

During the first quarter of fiscal year 2011, the Company changed the method it uses to allocate corporate overhead costs to its reportable segments. The result is that all corporate overhead is now allocated except for those amounts associated with the Company’s operation as a public entity, stock-based compensation expenses and certain miscellaneous expenses. The costs are allocated based on segment net sales. The Company’s Wood Treating Chemicals business is comprised of its Penta and Creosote reportable segments. Its other reportable segments include Electronic Chemicals and Animal Health. Prior year segment operating income amounts have been revised to reflect the current method.

1 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,471.37 -207.33 -1.17%
S&P 500 2,036.82 -20.27 -0.99%
NASDAQ 4,707.2080 -64.5550 -1.35%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs